Constitutive expression of ectopic c-Myc delays glucocorticoid-evoked apoptosis of human leukemic CEM-C7 cells

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Oncogene

• Publication date

  2001-08-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1204680PMID 11498786PMCID PMC2761604
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nuclear chromatin texture and sensitivity to DNase I in human leukaemic CEM cells incubated with nanomolar okadaic acid

  2000cited by this paper
• Sensitivity to myc-induced apoptosis is retained in spontaneous and transplanted lymphomas of CD2-mycERTM mice

  2000cited by this paper
• Hormonal regulation of physiological cell turnover and apoptosis

  2000cited by this paper
• Screening of five specific cell cycle inhibitors using a T cell lymphoma cell line synchrony/release assay.

  1999cited by this paper
• New Myc-interacting proteins: a second Myc network emerges

  1999cited by this paper
• c-Myc does not prevent glucocorticoid-induced apoptosis of human leukemic lymphoblasts

  1999cited by this paper
• Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia.

  1999cited by this paper
• A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with MYC

  1999cited by this paper
• Mechanisms of T-cell Apoptosis Induced by Glucocorticoids.

  1999cited by this paper
• Involvement of c‐myc in the resistance of non‐obese diabetic mice to glucocorticoid‐induced apoptosis

  1998cited by this paper
• Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.

  1998influential reference
• Sex difference in resistance to dexamethasone-induced apoptosis in NOD mice: treatment with 1,25(OH)2D3 restores defect.

  1998cited by this paper
• The many roles of c-Myc in apoptosis.

  1998cited by this paper
• Inhibition of G1 cyclin-dependent kinase activity in cell density-dependent growth arrest in human fibroblasts.

  1998cited by this paper
• The molecular role of Myc in growth and transformation: recent discoveries lead to new insights

  1998cited by this paper
• Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers

  1998cited by this paper
• Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c

  1998cited by this paper
• Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27Kip1 binding to newly formed complexes

  1997cited by this paper
• Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes

  1997cited by this paper
• An alternative pathway for gene regulation by Myc

  1997cited by this paper
• Growth arrest by the cyclin‐dependent kinase inhibitor p27Kip1 is abrogated by c‐Myc.

  1996cited by this paper
• Different Interleukin-1β Converting Enzyme (ICE) Family Protease Requirements for the Apoptotic Death of T Lymphocytes Triggered by Diverse Stimuli

  1996cited by this paper
• Role of c-jun induction in the glucocorticoid-evoked apoptotic pathway in human leukemic lymphoblasts.

  1996cited by this paper
• An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc

  1996cited by this paper
• Cdc25 cell-cycle phosphatase as a target of c-myc

  1996cited by this paper
• Glucocorticoid‐induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor.

  1995cited by this paper
• Glucocorticoid-induced death of immune cells: mechanisms of action.

  1995cited by this paper
• Glucocorticoid regulation of cyclin D3 gene transcription and mRNA stability in lymphoid cells.

  1995cited by this paper
• c-Myc and Max transregulate the mouse ornithine decarboxylase promoter through interaction with two downstream CACGTG motifs.

  1995cited by this paper
• Glucocorticoid Antagonist RU 486 Reverses Agonist‐Induced Apoptosis and C‐Myc Repression in Human Leukemic CEM‐C7 Cells

  1995cited by this paper
• An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants

  1995cited by this paper
• c-Myc and cyclin D3 (CcnD3) genes are independent targets for glucocorticoid inhibition of lymphoid cell proliferation.

  1995influential reference
• A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins.

  1995influential reference
• Differential induction of apoptosis in human breast tumor cells by okadaic acid and related inhibitors of protein phosphatases 1 and 2A.

  1994cited by this paper
• Apoptosis and the cell cycle.

  1994cited by this paper
• Repression of cyclin D1: a novel function of MYC.

  1994cited by this paper
• Heat shock protein is tightly associated with the recombinant human glucocorticoid receptor:glucocorticoid response element complex.

  1994cited by this paper
• Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2

  1993cited by this paper
• Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis.

  1993cited by this paper
• c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif.

  1993cited by this paper
• Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas.

  1992cited by this paper
• Different effects of staurosporine, an inhibitor of protein kinases, on the cell cycle and chromatin structure of normal and leukemic lymphocytes.

  1992cited by this paper
• Induction of apoptosis in fibroblasts by c-myc protein.

  1992cited by this paper
• Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.

  1991cited by this paper
• Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.

  1991cited by this paper
• Evidence for early induction of calmodulin gene expression in lymphocytes undergoing glucocorticoid-mediated apoptosis.

  1991cited by this paper
• Control of c-myc regulation in normal and neoplastic cells.

  1991cited by this paper
• Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines

  1990cited by this paper
• Glucocorticoid effect on oncogene/growth gene expression in human T lymphoblastic leukemic cell line CCRF-CEM. Specific c-myc mRNA suppression by dexamethasone.

  1989cited by this paper
• A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor.

  1988cited by this paper
• Glucocorticoid inhibition of c-myc, c-myb, and c-Ki-ras expression in a mouse lymphoma cell line.

  1986cited by this paper
• Metabolism of c‐myc gene products: c‐myc mRNA and protein expression in the cell cycle.

  1985cited by this paper
• Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product

  1985cited by this paper
• Isolation and characterization of lymphosarcoma P1798 variants selected for resistance to the cytolytic effects of glucocorticoids in vivo and in culture.

  1984cited by this paper
• Glucocorticoid receptors and steroid sensitivity in normal and neoplastic human lymphoid tissues: a review.

  1984cited by this paper
• Cellular oncogenes and retroviruses.

  1983cited by this paper
• Dexamethasone induces irreversible G1 arrest and death of a human lymphoid cell line

  1979cited by this paper
• Long-term incubation of rat thymus cells: Cytolytic actions of glucocorticoids in vitro.

  1975cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Trends in Endocrinology

  1969cited by this paper
• Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia

  1965cited by this paper

• Honokiol induces apoptosis and autophagy in dexamethasone-resistant T-acute lymphoblastic leukemia CEM-C1 cells

  2024cites this paper
• Roles of noncoding RNAs in drug resistance in multiple myeloma

  2020cites this paper
• Gene Expression and Resistance to Glucocorticoid-Induced Apoptosis in Acute Lymphoblastic Leukemia: A Brief Review and Update.

  2020cites this paper
• Sequential gene regulatory events leading to glucocorticoid-evoked apoptosis of CEM human leukemic cells:interactions of MAPK, MYC and glucocorticoid pathways.

  2018cites this paper
• Label propagation defines signaling networks associated with recurrently mutated cancer genes

  2018cites this paper
• Drug resistance in multiple myeloma.

  2018cites this paper
• Trehalose induces functionally active conformation in the intrinsically disordered N-terminal domain of glucocorticoid receptor

  2016cites this paper
• Regulation of Bim in Health and Disease

  2015cites this paper
• Low-dose anisomycin sensitizes glucocorticoid-resistant T-acute lymphoblastic leukemia CEM-C1 cells to dexamethasone-induced apoptosis through activation of glucocorticoid receptor and p38-MAPK/JNK

  2014cites this paper
• Epigenetic alteration by DNA-demethylating treatment restores apoptotic response to glucocorticoids in dexamethasone-resistant human malignant lymphoid cells

  2014cites this paper
• MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies

  2013cites this paper
• Integrative Modelling of Glucocorticoid Induced Apoptosis with a Systems Biology Approach

  2013influential citation
• Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia

  2013cites this paper
• Research resource: transcriptional response to glucocorticoids in childhood acute lymphoblastic leukemia.

  2012cites this paper
• Glucocorticoid and proteasome inhibitor impact on the leukemic lymphoblast: multiple, diverse signals converging on a few key downstream regulators.

  2012cites this paper
• The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer

  2012cites this paper
• Elucidating the identity of resistance mechanisms to prednisolone exposure in acute lymphoblastic leukemia cells through transcriptomic analysis: A computational approach

  2011cites this paper
• Evaluation of the NOD/SCID xenograft model for glucocorticoid-regulated gene expression in childhood B-cell precursor acute lymphoblastic leukemia

  2011cites this paper
• Glucocorticoid receptor knock down reveals a similar apoptotic threshold but differing gene regulation patterns in T-cell and pre-B-cell acute lymphoblastic leukemia.

  2010cites this paper
• Converting cell lines representing hematological malignancies from glucocorticoid-resistant to glucocorticoid-sensitive: signaling pathway interactions.

  2009cites this paper
• Stepping stones in the path of glucocorticoid-driven apoptosis of lymphoid cells.

  2008cites this paper
• Proteomic evaluation of pathways associated with dexamethasone‐mediated apoptosis and resistance in multiple myeloma

  2007cites this paper
• The glucorcorticoid receptor is increased in Atm−/− thymocytes and in Atm−/− thymic lymphoma cells, and its nuclear translocation counteracts c-myc expression

  2007cites this paper
• Protein Kinase A, not Epac, Suppresses Hedgehog Activity and Regulates Glucocorticoid Sensitivity in Acute Lymphoblastic Leukemia Cells*

  2007cites this paper
• The glucocorticoid receptor is increased in Atm-/- thymocytes and in Atm-/- thymic lymphoma cells, and its nuclear translocation counteracts c-myc expression.

  2007cites this paper
• Calcium-dependent upregulation of E4BP4 expression correlates with glucocorticoid-evoked apoptosis of human leukemic CEM cells.

  2006cites this paper
• Molecular mechanisms of glucocorticoid resistance in childhood acute lymphoblastic leukemia

  2006cites this paper
• Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia.

  2006cites this paper
• p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211.

  2005cites this paper
• Early lymphoid progenitors in mouse and man are highly sensitive to glucocorticoids.

  2005cites this paper
• Prolactin induces c-Myc expression and cell survival through activation of Src/Akt pathway in lymphoid cells

  2004cites this paper
• Cyclin D3 and c-MYC control glucocorticoid-induced cell cycle arrest but not apoptosis in lymphoblastic leukemia cells

  2004cites this paper
• Overexpression of catalase or Bcl-2 alters glucose and energy metabolism concomitant with dexamethasone resistance.

  2004cites this paper
• Regulation of a distinctive set of genes in glucocorticoid-evoked apoptosis in CEM human lymphoid cells.

  2003cites this paper
• Regulation of a distinctive set of genes in glucocorticoid-evoked apoptosis in CEM human lymphoid cells.

  2003cites this paper
• Potential Involvement of Calcineurin in Regulating the State of Differentiation and Apoptosis of HL-60 Cells During Methylprednisolone-Treatment.

  2003cites this paper
• Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia.

  2003cites this paper
• Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia

  2003cites this paper
• Microarray Analysis Uncovers the Induction of the Proapoptotic BH3-only Protein Bim in Multiple Models of Glucocorticoid-induced Apoptosis*

  2003cites this paper
• A conceptual view on glucocorticoid-lnduced apoptosis, cell cycle arrest and glucocorticoid resistance in lymphoblastic leukemia.

  2003cites this paper
• Apoptosis, Glucocorticoid-Induced

  2003cites this paper
• ACTH promotion of p27(Kip1) induction in mouse Y1 adrenocortical tumor cells is dependent on both PKA activation and Akt/PKB inactivation.

  2002cites this paper
• IL-7-mediated protection of pro and pre-B cells from the adverse effects of corticosterone.

  2002cites this paper
• Glucocorticoids and polyamine inhibitors synergize to kill human leukemic CEM cells.

  2002influential citation
• Microarray-based expression profiling of normal and malignant immune cells.

  2002cites this paper